The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetes ...
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results